Table 1

Summary of the 10 cases of extramedullary myeloid tumours involving the mediastinum that have reported karyotypic data

Case	Age/ sex	Blast cells in PB	Bone marrow	FAB	Immunophenotype	Pleural involvement	Karyotype	Remission	Outcome	Ref
Chemo, chemotherapy; F, female; M, male; N/A, not available; N/D, not determined; PB, peripheral blood.
1	21/M	Yes	Yes	M₃	N/D	No	Tetraploidy	Yes	Death, relapse	14
2	45/F	Yes	Yes	M₂	CD7/13/33⁺, HLA-DR⁻	No	Del (15)(q13q15)	Yes	Death, relapse	15
3	4.5/M	No	No	M₄/M₅	CD33⁺, HLA-DR⁺	Yes	t(9;11)(p22;q23)	Yes	Remission 18+ months	16
4	29/F	No	No	M₂	CD34/33⁺, CD13⁻	No	Diploid/ near triploid/ near tetraploid	No	Refractory death post allotransplant	17
5	46/F	Yes	Yes	M₄	CD34/7/33⁺, CD13⁻	No	Diploid/ near tetraploid	Yes	Death, relapse	17
6	29/F	Yes	Yes	M₁	N/A	No	Near triploid/ near tetraploid	Yes	Death, relapse	17
7	34/F	No	No	M₂	CD33⁺, HLA-DR⁺	Yes	^-10, ^-11	No	Death, refractory disease	18
8	42/F	No	No	M₀	CD7/34/33⁺, CD13⁺	No	15, +19, +20	Yes	Death, heart failure	19
9	26/M	No	Yes	RAEB	CD33⁺	Yes	Normal	N/A	Death, post chemo	20
10	17/F	No	N/D	M₁	CD7/65/CD56⁺, HLA-DR⁺, CD13/33⁻	Yes	Near triploid/ near tetraploid	No	Death	This paper